Product Code: BIO229A
Highlights:
The global sepsis diagnostic market should reach $837 million by 2026 from $587.6 million in 2021 at a compound annual growth rate (CAGR) of 7.3% for the forecast period of 2021 to 2026.
The North American sepsis diagnostic market is expected to grow from $283.8 million in 2021 to $417.1 million in 2026 at a CAGR of 8.0% for the forecast period of 2021 to 2026.
The European sepsis diagnostic market is expected to grow from $164.7 million in 2021 to $234.6 million in 2026 at a CAGR of 7.3% for the forecast period of 2021 to 2026.
Report Scope:
The current report provides detailed exposure to the sepsis diagnostic market. This report highlights the current and future market potential of sepsis diagnostics, as well as a detailed analysis of market drivers, challenges and opportunities. The report also covers market projections to 2026 and market shares for key market players. It details the market share of sepsis diagnostics based on technology type, product, diagnostic method and pathogen type. The report includes company profiles of the key players, with detailed information regarding their business segments, financials, product portfolios and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.
The regional market has been segmented into North America, Europe, Asia-Pacific and the Rest of the world. For market estimates, data have been provided for 2019 as the historic year and 2020 as the base year, with a forecast for 2026.
Report Includes:
- 35 data tables and 15 additional tables
- An updated overview of the global sepsis diagnostics market
- Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for sepsis diagnostics, and corresponding market share analysis by product, technology type, diagnostic method, test type, pathogen, end user and geographic region
- Highlights the current and future market potential of sepsis diagnostics along with a detailed analysis of the drivers, challenges, and opportunities in the market
- Identification of promising new products and technologies still in the development and assess the probability that they will be commercialized successfully in the next five years
- Discussion of the COVID-19 implications on the market for sepsis clinical diagnostics and research studies
- Information pertaining to the companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Insight into the recent industry structure, current competitive scenario, R&D activities, product launch strategies and company value share analysis based on their segmental revenues
- Descriptive company profiles of the leading global players, including Abbott Laboratories, Bruker Corp., Roche Diagnostics Corp., Siemens Healthineers AG and Thermo Fisher Scientific Inc.
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Technology Background
- Introduction
- Causes
- Risk Factors
- Symptoms
- Pathophysiology
- Endothelial Dysfunction
- Coagulopathy
- Cardiovascular Dysfunction
- Cellular Dysfunction
- Epidemiology and Economic Burden
- Diagnosis and Treatment
- Regulatory Scenario
- Regulations in North America
- European Regulations
Chapter 4 Market Dynamics
- Factors Affecting the Sepsis Diagnostic Market
- Market Drivers
- Increasing Incidence of Infectious Diseases
- Rising Aging Population and Increasing Incidence of Chronic Diseases
- Increasing Government Initiatives
- Technological Developments
- Market Restraints
- High Cost of Instruments and Lack of Skilled Workforce
- Opportunities
- Demand for Rapid and Accurate Diagnostic Tool
Chapter 5 Impact of COVID-19
- Introduction
- Outbreak
- COVID-19 Symptoms
- COVID-19 Progression
- Incubation Period
- Epidemiology
- Collaboration Between Organizations and Governments
- Spread of Disease
- Impact of COVID-19 on the Sepsis Diagnostic Market
Chapter 6 Sepsis Diagnostic Market by Technology
- Global Sepsis Diagnostic Market by Technology
- Microbiological Tests
- Immunoassays
- Molecular Diagnostics
- Others
Chapter 7 Sepsis Diagnostic Market by Product
- Assays and Reagents
- Culture Media
- Instruments
- Software
Chapter 8 Sepsis Diagnostic Market by Method
- Conventional Diagnostics
- Automated Diagnostics
Chapter 9 Sepsis Diagnostic Market by Test Type
- Laboratory Tests
- Point-of-Care Tests
Chapter 10 Sepsis Diagnostic Market by Pathogen Type
- Bacterial Sepsis
- Fungal Sepsis
- Others
Chapter 11 Sepsis Diagnostic Market by End User
- Hospitals and Clinics
- Diagnostic Centers
- Academic and Research Institutions
Chapter 12 Sepsis Diagnostic Market by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 13 Competitive Landscape and Analysis of Market Opportunities
- Mergers, Acquisitions and Collaborations
- Sepsis Diagnostic Company Market Shares
Chapter 14 Company Profiles
- ABBOTT LABORATORIES
- AXIS-SHIELD DIAGNOSTICS LTD.
- BECTON, DICKINSON & COMPANY
- BIOMERIEUX
- BRUKER CORP.
- DANAHER
- EKF DIAGNOSTICS HOLDINGS PLC
- IMMUNEXPRESS
- LUMINEX CORP.
- QIAGEN NV
- ROCHE DIAGNOSTICS CORP.
- SEEGENE
- SIEMENS HEALTHINEERS AG
- T2 BIOSYSTEMS
- THERMO FISHER SCIENTIFIC INC.